Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Reed Hastings says Big Tech should get used to being hated - like Big Pharma
Reed Hastings thinks the tech industry has some Big Pharma energy. During an interview with 'On with Kara Swisher,' released on Monday, the Netflix founder and former co-CEO responded to questions about the unpopularity of Silicon Valley…
Economic Times Reports Piramal Pharma Led Four-Stock RSI Screen
The Economic Times reported that Piramal Pharma Limited led a four-stock Indian momentum screen on Oct. 28, when each selected share rose more than 6%. The outlet put Piramal Pharma's Relative Strength Index (RSI) at 71.93, compared with 49.11…
Pharma giants Merck, Eli Lilly face earnings health check (MRK:NYSE)
Pharmaceutical giants Merck (MRK) and Eli Lilly (LLY) are scheduled to report third-quarter results on October 29, with analysts expecting a year-on-year earnings decline in both cases. Merck's per share earnings are projected to drop 19% to $2.09…
MAGA Senator Sure Picked Perfect Time to Buy Pharma Stock
Senator Roger Marshall made a conveniently timed stock purchase in 2018—but his position on the Health, Education, Labor, and Pensions, or HELP, Committee could juice the deal even more. Eight years ago on November 8, when he was still a…
Schott Poonawalla now becomes Schott Pharma, as it strengthens presence in specialty glass market
Updated - October 28, 2026 at 09:18 PM. Specialty glass company Schott Poonawalla Private Ltd will become Schott Pharma India Private Ltd, from Wednesday - strengthening its connection with German parent Schott Pharma, besides marking a new journey…
3 Big Pharma Earnings Reports to Watch: Eli Lilly, Merck and Gilead
Eli Lilly's EPS estimate collapsed by a third in just 30 days, Merck faces a comparison it cannot repeat, and Gilead is burning through cash fast. Three pharma giants report Thursday, and the results could reshape the sector's outlook for……
Marshall purchased stock in obscure pharma company just before it secured key FDA approval
On November 8, 2018, then-Congressman Roger Marshall (R-KS) and his wife completed a purchase of 1,250 shares of Ionics Life Sciences, a privately held company, according to documents from the Irish Companies Registration Office obtained by Popular…
BridgeBio Pharma (NASDAQ:BBIO) Stock Price Breaks Above 50-Day Moving Average - Here's Why
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) passed above its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of $70.70 and traded as high as $71.18. BridgeBio Pharma shares last traded at $70.82…
Spyglass Pharma (NASDAQ:SGP) Sets New 12-Month High - Still a Buy?
Shares of Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) reached a new 52-week high on Wednesday. The stock traded as high as $32.85 and last traded at $33.1310, with a volume of 105,033 shares. The stock had previously closed at $30.90.
RFK Jr. Allows Unapproved Peptides on the Market
Health Secretary Robert F. Kennedy Jr. is temporarily allowing six unapproved peptides on the market, despite warnings from government scientists that there isn't enough evidence to prove they are safe or effective. In a policy released Wednesday…
Q2 Results 29th Oct Live: Coal India, Asian Paints, IndiGo, Trent, Laurus Labs, Ambuja Cements, Godrej Consumer, Welspun Corp, Apar Industries, Motilal Oswal, Blue Star, Strides Pharma, Milky Mist to announce Q2 results, Adani Ports, Hyundai, PVR Inox, Chola Finance, Meesho, Satin Creditcare, Birlas
Q2 Results Today, 29th October 2026 Live Updates: Find all the latest Q2 results 2026 updates of Twentyfirst Century Management Services, 3i Infotech, Archean Chemical Industries, Anlon Healthcare, Alchemist Corporation, Alivus Life Sciences…
Eli Lilly is about to report earnings. Here's what to expect
Eli Lilly is slated to report third-quarter earnings and revenue on Thursday. The results will likely be fueled by its blockbuster obesity drug Zepbound and diabetes counterpart Mounjaro. Investors will also be focused on the company's obesity pill…
Biotechs buck a sluggish IPO market, but investors should tread warily
With all of the excitement around the highly anticipated Anthropic initial public offering, it might be easy to forget that this year hasn't always been smooth sailing for many prospective stock debuts. In September, OpenAI, Anthropic's chief…
Richard Sackler loses bid to keep mansion despite Purdue settlement
Oct 28 (Reuters) – A US bankruptcy judge on Wednesday ruled that Richard Sackler and his wife Lin Gao must stop interfering with efforts to sell their Connecticut mansion to help pay for Purdue Pharma's $7.4 billion bankruptcy settlement…
3 battlegrounds where ticket-splitting could make the difference
A handful of key gubernatorial and Senate contests in battleground states could hinge on split-ticket voters as Republicans look to keep control of both offices. Split-ticket voting has dwindled in recent cycles: A Decision Desk HQ (DDHQ) forecast…
Receive a Daily briefing on Pharma Industry News
Get Started